Mostrando 7 resultados de: 7
Filtros aplicados
Bases moleculares de los principales polimorfismos del gen CYP2D6, diferencias étnicas y consecuencias farmacológicas
OtherAbstract: El gen CYP2D6 metaboliza aproximadamente el 25% de fármacos de uso clínico y exhibe una marcada variPalabras claves:Autores:MELANIE BRIGETTE ARROYO LOPEZFuentes:googleEstudios farmacogenéticos en la enfermedad de Alzheimer
OtherAbstract: Introduction Alzheimer disease (AD) is the most common cause of dementia and is considered one of thPalabras claves:Autores:MELANIE BRIGETTE ARROYO LOPEZFuentes:googlePP139—Association of ABCB1, ABCC2, CYP2C9 and CYP2C19 polymorphism with phenytoin plasma concentrations
OtherAbstract: Aim To evaluate the association of CYP2C9, CYP2C19, ABCB1, and ABCC2 polymorphism on PHT plasma levePalabras claves:Autores:MELANIE BRIGETTE ARROYO LOPEZFuentes:googlePP143—Impact of UGT1A4 genotype in the clinical response to lamotrigine in patients with epilepsy
OtherAbstract: Aims To investigate the impact of UGT1A4* 1b, UGT1A4* 2 and UGT1A4* 3b polymorphism on LTG plasma lePalabras claves:Autores:MELANIE BRIGETTE ARROYO LOPEZFuentes:googlePharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response
ReviewAbstract: Carbamazepine (CBZ) is a first-line widely used anticonvulsant. It has a narrow therapeutic index anPalabras claves:adverse drug reaction, carbamazepine, Drug resistance, genetic polymorphism, human leukocyte antigen (HLA), pharmacogeneticsAutores:Adrián LLerena, Cook H.J., Galindo I.F., López M.L., MELANIE BRIGETTE ARROYO LOPEZ, Monroy-Jaramillo N., Vázquez A.O.Fuentes:googlescopusPharmacogenetic studies in Alzheimer disease
OtherAbstract: Introduction Alzheimer disease (AD) is the most common cause of dementia and is considered one of thPalabras claves:Autores:MELANIE BRIGETTE ARROYO LOPEZFuentes:googlePharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine
ReviewAbstract: Patients treated with antiepileptic drugs can exhibit large interindividual variability in clinicalPalabras claves:antiepileptic drug, Cytochrome p450, lamotrigine, pharmacogenetics, Phenytoin, UDP-glucuronosyltransferase (UGT)Autores:Adrián LLerena, Dorado P., ElisaAlonso M., Jung-Cook H., López M.L., Machín E., MELANIE BRIGETTE ARROYO LOPEZ, Monroy-Jaramillo N., Penãs-Lledó E.M.Fuentes:googlescopus